FOCUS ON SIMVASTATIN - A POTENT HMG-COA REDUCTASE INHIBITOR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA

被引：0
|
作者：
QUERCIA, RA
机构：
来源：
HOSPITAL FORMULARY | 1989年 / 24卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：559 / &
相关论文
共 50 条
  • [41] SYNTHESIS OF A NOVEL HMG-COA REDUCTASE INHIBITOR
    BAADER, E
    BARTMANN, W
    BECK, G
    BERGMANN, A
    JENDRALLA, H
    KESSELER, K
    WESS, G
    SCHUBERT, W
    GRANZER, E
    VONKEREKJARTO, B
    KRAUSE, R
    TETRAHEDRON LETTERS, 1988, 29 (08) : 929 - 930
  • [42] In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor
    Feleszko, W
    Mlynarczuk, I
    Nowis, D
    FEBS LETTERS, 2001, 503 (2-3) : 219 - 220
  • [43] PREVENTIVE EFFECT OF MK-733 (SIMVASTATIN), AN INHIBITOR OF HMG-COA REDUCTASE, ON HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS INDUCED BY CHOLESTEROL FEEDING IN RABBITS
    KOBAYASHI, M
    ISHIDA, F
    TAKAHASHI, T
    TAGUCHI, K
    WATANABE, K
    OHMURA, I
    KAMEI, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 1989, 49 (01): : 125 - 133
  • [44] TREATMENT OF FAMILIAL AND NONFAMILIAL HYPERCHOLESTEROLEMIA - A REVIEW OF HMG-COA REDUCTASE INHIBITORS AND PROBUCOL
    TIKKANEN, MJ
    HELVE, E
    NIKKILA, EA
    EUROPEAN HEART JOURNAL, 1987, 8 : 97 - 101
  • [45] Responses to the inhibition of HMG-CoA reductase: A comparison of simvastatin and atorvastatin
    Bergstrom, JD
    Bostedor, RG
    Rew, DJ
    Geissler, WM
    Wright, SD
    Chao, YS
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 121 - 121
  • [46] TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA WITH SYNVINOLIN - NEW HMG COA REDUCTASE INHIBITOR
    STEIN, EA
    LAMKIN, GE
    OLIVERA, EH
    BEWLEY, DZ
    ARTERIOSCLEROSIS, 1987, 7 (05): : A514 - A515
  • [47] Dissolution of Gallstones with Simvastatin, an HMG CoA Reductase Inhibitor
    B. A. Chapman
    M. J. Burt
    R. J. Chisholm
    R. B. Allan
    K. H. J. Yeo
    A. G. Ross
    Digestive Diseases and Sciences, 1998, 43 : 349 - 353
  • [48] Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor
    Chapman, BA
    Burt, MJ
    Chisholm, RJ
    Allan, RB
    Yeo, KHJ
    Ross, AG
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (02) : 349 - 353
  • [49] The role of HMG-CoA reductase inhibitors in homozygous familial hypercholesterolemia
    Marais, AD
    Firth, JC
    Naoumova, RP
    Thompson, GR
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 181 - 186
  • [50] Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin
    Franco Bernini
    Andrea Poli
    Rodolfo Paoletti
    Cardiovascular Drugs and Therapy, 2001, 15 : 211 - 218
12345